BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,021.63
0.57%
US Tech 100
20,367.60
0.51%
Dow Jones
44,860.31
0.28%
Brent Oil
72.425
-0.03%
Bitcoin
92,700.65
0.79%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Genflow Biosciences Plc (GENF) Quote

Genflow Biosciences Plc

Genflow Biosciences Plc (GENF)

LSE
1.73
0.005
(0.29%)
Closed November 27 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.73
Bid
1.55
Ask
1.70
Volume
2,133,983
1.625 Day's Range 1.725
1.35 52 Week Range 3.30
Market Cap
6.05M
Previous Close
1.725
Open
1.725
Last Trade
9697
@
1.73
(UT)
Last Trade Time
Financial Volume
36,865p
VWAP
1.7275
Average Volume (3m)
637,120
Shares Outstanding
349,706,618
Dividend Yield
-
PE Ratio
-3.45
Earnings Per Share (EPS)
-0
Revenue
169k
Net Profit
-1.63M

About Genflow Biosciences Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.genflowbio.com
Headquarters
London, Gbr
Founded
-
Genflow Biosciences Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GENF. The last closing price for Genflow Biosciences was 1.73p. Over the last year, Genflow Biosciences shares have traded in a share price range of 1.35p to 3.30p.

Genflow Biosciences currently has 349,706,618 shares outstanding. The market capitalization of Genflow Biosciences is £6.03 million. Genflow Biosciences has a price to earnings ratio (PE ratio) of -3.45.

Ask ADVFN Intelligence (AI)

GENF Latest News

More News

Genflow Biosciences secures EUR4 million for liver disease treatment

Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, t ...

October 22 2024
Alliance News

Genflow Biosciences PLC Genflow Secures Non-Dilutive Financial Support

Genflow Biosciences PLC 22 October 2024     THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE...

October 22 2024
RNS Regulatory News

Genflow Biosciences PLC Half-year Report

Genflow Biosciences PLC 30 September 2024   PRESS RELEASE   30 September 2024 Genflow Biosciences Plc   ("Genflow" or "the Company")   HALF YEAR RESULTS     Genflow (LSE: GENF) is pleased to...

September 30 2024
RNS Regulatory News

Genflow Biosciences Plc to Present at the Life Sciences Investor Forum September 19th

LONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (LSE:GENF OTCQB:GENFF), based in the UK, focused on pioneering gene therapies to decelerate the aging process, today...

September 16 2024
GlobeNewswire Inc.

EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

June 27 2024
Alliance News

Genflow Biosciences PLC Result of AGM

Genflow Biosciences PLC 27 June 2024     27 June 2024 Genflow Biosciences Plc Results of Annual General Meeting     Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF) ("Genflow" or "the...

June 27 2024
RNS Regulatory News

Genflow Biosciences PLC Strengthening of Pre-Clinical Efforts

Genflow Biosciences PLC 27 June 2024     THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE...

June 27 2024
RNS Non-Regulatory

EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant

The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...

June 12 2024
Alliance News

Genflow Biosciences PLC Receipt of Grant Funding

Genflow Biosciences PLC 12 June 2024     THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE...

June 12 2024
RNS Regulatory News

Genflow Biosciences PLC Notice of AGM

Genflow Biosciences PLC 03 June 2024     3 June 2024 Genflow Biosciences Plc Notice of Annual General Meeting Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an...

June 03 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-3.888888888891.81.81.6255871191.74482971DE
4-0.07-3.888888888891.81.91.6253642441.76947879DE
12-0.52-23.11111111112.252.31.6256371201.91852188DE
26-0.97-35.92592592592.73.31.6256698442.37804649DE
52-0.07-3.888888888891.83.31.359675391.99404275DE
156-7.52-81.29729729739.2513.251.3510345252.98078611DE
260-7.52-81.29729729739.2513.251.3510345252.98078611DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ORCPOracle Power Plc
0.0305p
(158.47%)
6.24B
STKStreaksai Plc
0.35p
(59.09%)
8.58M
QEDQuadrise Plc
3.62p
(57.39%)
94.06M
ENWEnwell Energy Plc
23.00p
(46.03%)
160.81k
WEBWebis Holdings Plc
0.125p
(38.89%)
9.14M
INXI-nexus Global Plc
1.50p
(-52.38%)
7.25M
SFRSeverfield Plc
55.60p
(-36.24%)
9.71M
LENDSancus Lending Group Limited
0.30p
(-33.33%)
1.23M
TRYBTribe Technology Plc
2.45p
(-20.97%)
80k
GWMOGreat Western Mining Corporation Plc
0.0175p
(-20.45%)
169.92M
ORCPOracle Power Plc
0.0305p
(158.47%)
6.24B
NTVONativo Resources Plc
0.0025p
(0.00%)
3.46B
TRPTower Resources Plc
0.0275p
(0.00%)
526.88M
CPXCap-xx Limited
0.145p
(-13.43%)
499.92M
MSMNMosman Oil And Gas Limited
0.038p
(-1.30%)
329.43M

Discussion

View Full Feed
RickNagra RickNagra 1 minute ago
Wrong.  Look again carefully.  I recommend zooming in.  It says com and not con.
FNMA
BamaBreeze BamaBreeze 5 minutes ago
The management would stand to make A lot of money. More than cheating shareholders out of theirs. That would be a major incentive I would think.
BLLB
jondoeuk jondoeuk 6 minutes ago
A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr
BGNE
gfp927z gfp927z 6 minutes ago
Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


Barron's

by Paul R. La Monica

Nov 22, 2024


https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
ACXP
dinogreeves dinogreeves 8 minutes ago
Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i
SMCI
bluebird50 bluebird50 8 minutes ago
Guess crows don't like coffee.... delete this post and Crows... 

;-) so we don't witness a murder... a group of crows... Che Che Che 
RDAR
BamaBreeze BamaBreeze 9 minutes ago
Good on you!! Bless us.
BLLB
ducci1 ducci1 9 minutes ago
Pivot Calcs: SPX Pivot--6012----R1--6033----R2--6045----S1--6000----S2--5980-----SPY Pivot--599----R1--601----R2--602----S1--598----S2--596-----VIX Pivot--14.33 !!LOL!!
VIX
imnot6 imnot6 9 minutes ago
Well, extended duration is their value proposition...
JohnnyHydrogen JohnnyHydrogen 10 minutes ago
AI Czar ?

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk

....

"The office would spur the massive private investment needed to expand the energy supply to keep the U.S. on the cutting edge."
FCEL
gfp927z gfp927z 11 minutes ago
Bigworld, Here's more info relating to Acurx's recent move to buy some Bitcoin (below). So far that boneheaded decision by Luci has cut Acurx's share price nearly in half -


Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

gfp927z gfp927z 15 minutes ago
Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


Barron's

by Paul R. La Monica

Nov 22, 2024


https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
Mountainman5 Mountainman5 15 minutes ago
Red Cat & OPT = WinWin!!!!!!!!!!!!!
OPTT
BDEZ BDEZ 17 minutes ago
Thanks georgie..
XRPUSD
$GROO $GROO 17 minutes ago
Never Quit $SANP
Never Quit $SANP $GROO ht
GROO SANP
Oleblue Oleblue 17 minutes ago
In this solo lecture, Chris Miller, author of the acclaimed book "Chip War", delves into the intricate world of semiconductors, exploring how microchips have become the cornerstone of global power and economic influence. Miller will provide an analysis of the geopolitical ramifications of semiconduc
NVDA
JettaR JettaR 19 minutes ago
No one is "rooting" for the stock to go down.  Eyes wide open. Eyes wide open. It's right on front of everyone. 
RGLG
lambchops lambchops 19 minutes ago
Peeps ought to gobble up some NFTM shares for gobble-gobble day!

Eat turkey--not lamb-- on Christmas! Yum-yum.

Happy T-bird day. And remember,"Fun. Fun, fun till your daddy takes the T-bird awayNFTM
NFTM
reaper247 reaper247 21 minutes ago
Always good to hear from ya Drugdoctor.

I suspect we have a few people lurking around.

Hope all GVSIers have as safe and happy Thanksgiving.

GLTA, IMO and FWIW.
GVSI
jondoeuk jondoeuk 22 minutes ago
One for FT819 as well https://www.globenewswire.com/news-release/2024/11/18/2982757/24675/en/Fate-Therapeutics-Presents-6-Month-Follow-up-Data-on-First-Patient-Treated-in-Phase-1-Autoimmunity-Study-with-Fludarabine-free-Conditioning-and-FT819-Off-the-shelf-1XX-CAR-T-cell-P.html
FATE
skitahoe skitahoe 22 minutes ago
NWBO is in a similar situation in the EU. I believe that you'll find that the 150 days doesn't begin with submission. No one is absolutely certain, some believed it started with preliminary validation, which occurred roughly a month after submission. Others believed it began with final validation
AVXL NWBO
jjjjjjjj jjjjjjjj 22 minutes ago
Gummies for dummies -- yummies , LMAO burger flipper
Reply privately from blusher.

Keep doing the 2 steps:
1. SET SELL HIGH our shares.
2. SET BUY HIGHssssssss with last minute and price limit.

MJNA is a good company. Best to us longs.
MJNA
jondoeuk jondoeuk 23 minutes ago
The PR https://www.globenewswire.com/news-release/2024/11/18/2982736/24675/en/Fate-Therapeutics-Highlights-FT522-Off-the-shelf-ADR-armed-CAR-NK-Cell-Product-Candidate-at-2024-ACR-Convergence.html
FATE
gfp927z gfp927z 24 minutes ago
Xena, All I said was that a B-12 deficiency might be the cause of your advancing foot numbness. Gadolinium toxicity might have the same effect (?), but logic says to eliminate other obvious possibilities before concluding that it is the gadolinium.

>> given the level of supplementa
jondoeuk jondoeuk 25 minutes ago
They need to pick up the pace of enrolment. If they don't see activity at DL2, I think it could be in trouble.
FATE

Your Recent History

LSE
GENF
Genflow Biosciences
EU
GOVEP
Euronext Eurozone Divers...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50